4//SEC Filing
Vignola Mark J. 4
Accession 0001562180-24-006794
CIK 0001831363other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 6:10 PM ET
Size
9.1 KB
Accession
0001562180-24-006794
Insider Transaction Report
Form 4
Vignola Mark J.
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-09-10−10,000→ 55,000 totalExercise: $5.36Exp: 2032-01-25→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2024-09-10$5.36/sh+10,000$53,600→ 101,940 total - Sale
Common Stock
2024-09-10$11.00/sh−10,000$110,000→ 91,940 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2024.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001775429
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 6:10 PM ET
- Size
- 9.1 KB